1446862-55-0

Basic information

• Product Name: 1-methyl-3-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxalinium iodide
• Synonyms: 1-methyl-3-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxalinium iodide
• CAS NO: 1446862-55-0
• Molecular Weight: 538.428
• Mol File: 1446862-55-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-methyl-3-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxalinium iodide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-methyl-3-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxalinium iodide(1446862-55-0)
• EPA Substance Registry System: 1-methyl-3-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxalinium iodide(1446862-55-0)

Safety Data

• Hazardous Substances Data: 1446862-55-0(Hazardous Substances Data)

Upstream product

• 1446862-97-0 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-carbomethoxy-4’-(t-butyl)-[1,1’]biphenyl 
• 1446862-95-8 3-bromo-5-carbomethoxy-4’-(t-butyl)-[1,1’]biphenyl 
• 123324-71-0 p-tert-butylphenylboronic acid 
• 188813-07-2 methyl 3-bromo-5-iodobenzoate 
• 36856-91-4 2-bromo-quinoxaline 
• 1446862-99-2 2-[[1,1'-biphenyl-5-(carboxymethyl)-4’-(t-butyl)]-3-yl]quinoxaline 
• 74-88-4 methyl iodide 

Relevant articles and documents

Antimicrobial agents

The invention provides methods of treating a bacterial infection in a mammal comprising administering to the mammal a substituted bicyclic heteroaromatic ring compound of formula I: wherein two of X1 to X8 are N and the remaining of X1 to X8 are CH; or a pharmaceutically acceptable salt thereof, as well as novel compounds of formula I and salts thereof and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof.

ANTIMICROBIAL AGENTS

The invention provides methods of treating a bacterial infection in a mammal comprising administering to the mammal a substituted bicyclic heteroaromatic ring compound of formula I: wherein two of X1 to X8 are N and the remaining of X1 to X8 are CH; or a pharmaceutically acceptable salt thereof, as well as novel compounds of formula I and salts thereof and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof.